Accès ouvert

Review of: "[Research Note] Semaglutide, a GLP-1 Agonist Like Ozempic, and Its Potential Role as a Preventive Anti-Cancer Agent"

Article scientifique 2023 Anglais

Résumé

must explain a molecular mechanism how Glp receptor activatoin inhibit cancer cell proliferation? 2. The authors stated that "the molecular dialogues orchestrated by Glp-1 receptor activation tilt the balance towards programmee cell death " , if it possible to explain that molecular mechanism 3. The used dose 0.5 mg didn't show any voimting as side effect as it well known that ozempic cause very offensive vomiting as side effect ,if not please add referenc for this point

Citer ce document

Yahia, H. (2023). Review of: "[Research Note] Semaglutide, a GLP-1 Agonist Like Ozempic, and Its Potential Role as a Preventive Anti-Cancer Agent". https://doi.org/10.32388/dxlbgk

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Auteur(s)

Haneen Yahia

Statistiques

Consultations : 1

Téléchargements : 0